Long Term Follow up of Toe-to-hand Transfers

June 27, 2024 updated by: Chang Gung Memorial Hospital

Long Term Follow up of Toe-to-hand Transfers: Validated Patient Reported Outcomes

Toe transfers are perceived to have changed the landscape of the injured hand over the last half century, yet there are limited validated data that unequivocally support the functional role of toe transfers after traumatic digital amputation. There also remain unanswered questions about what factors critically influence functional outcomes, be it sensory recovery, grip strength or other modality. Furthermore, the use of validated patient reported outcome measures (PROMs) in large series of toe transfers with long term follow up, is lacking.

Study Overview

Detailed Description

Finger amputations are associated with profound impacts on physical, socio-economic, vocational and mental well-being. Thumb amputations account for the greatest burden of disability globally amongst hand trauma.

The multi-centre FRANCHISE study and a recent large prospective multi-centre study have demonstrated that finger replantation outperforms equivalent amputations in nearly all digits at all levels, except for the little finger. However, one crucial question in hand surgery is whether toe transfers can provide a similar functional benefit to replantation.

Finger amputations are frequently not replantable even with timely access to specialized reconstructive care. A review of replantation in the USA found that of 3,417 digital amputations, only 631 replantations were attempted (18%), and of these 30% failed. Therefore nearly 90% of patients with finger amputations will ultimately live without the amputated digit.

Microvascular toe-to-hand transfer, first described in the 1960s, has a success rate close to 100% in high volume centres. There are few validated data that support the functional benefits of toe transfer, with the majority of outcome studies focusing on operative survival rates, physical measurements such as grip strength, or employ unvalidated scales and self-created questionnaires. More data, in larger more representative populations, using validated PROMs, is required.

Here, we aim to demonstrate using PROMS that the role of toe transfers has equivalent or improved functional benefits, with comparison to finger replantation. Additionally, this study aims to identify physical factors that have the greatest influence on patient reported outcomes. This may answer fundamental questions regarding optimum strategies for the design of toe transfers.

Study Type

Observational

Enrollment (Actual)

75

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients operated on by single surgeon (FCW) at Chang Gung Memorial Hospital from 1983 to 2015, with at least 5 years follow up at time of inclusion to study

Description

Inclusion Criteria:

  • Toe transfers
  • minimum 5 year follow up

Exclusion Criteria:

  • partial toe transfers including toenail, toe pulp or vascularised joint
  • under 5 year follow up

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Toe transfer
Patients who have undergone toe to hand transfer
Toe-to-hand transfer
Replantation
Patients who have undergone finger replantation
Finger or thumb replantation after amputation
Other Names:
  • Finger or thumb replantation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Michigan Hand Questionnaire
Time Frame: Single time-point, on average 22 years after surgery
Validated Hand function patient reported outcome measured. 0-100. Higher is better
Single time-point, on average 22 years after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short Form 36
Time Frame: Single time-point, on average 22 years after surgery
Short Form 36 Quality of Life. 0-100. Higher is better
Single time-point, on average 22 years after surgery
Foot Function Index
Time Frame: Single time-point, on average 22 years after surgery
Validated foot function Patient reported outcome measure. 0-100. Lower is better
Single time-point, on average 22 years after surgery
Aesthetic evaluation
Time Frame: Longitudinal. 3 timepoints: 1 day before surgery, 1 day after surgery, and on average 22 years after surgery
Subjective evaluation of toe transfer appearance using a Visual Analogue Scale, not validated
Longitudinal. 3 timepoints: 1 day before surgery, 1 day after surgery, and on average 22 years after surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of motion
Time Frame: Single time-point, on average 22 years after surgery
Total active range of motion of digit. Measured in degrees per digit
Single time-point, on average 22 years after surgery
Grip strength
Time Frame: Single time-point, on average 22 years after surgery
Measured with hand dynamometer. Measured in kilograms.
Single time-point, on average 22 years after surgery
Sensation
Time Frame: Single time-point, on average 22 years after surgery
Measured with discriminator device. Two point discrimination measured in millimetres
Single time-point, on average 22 years after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fu Chan Wei, FACS, Chang Gung Memorial Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 31, 2015

Primary Completion (Actual)

October 27, 2023

Study Completion (Actual)

October 27, 2023

Study Registration Dates

First Submitted

May 5, 2024

First Submitted That Met QC Criteria

June 27, 2024

First Posted (Actual)

July 5, 2024

Study Record Updates

Last Update Posted (Actual)

July 5, 2024

Last Update Submitted That Met QC Criteria

June 27, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 201505775B0C104

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Data subject to privacy and legal restrictions - not yet decided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patient Reported Outcome Measures

Clinical Trials on Toe transfer

Subscribe